Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Azacitidine + Venetoclax + NK Cells for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing if adding special immune cells from a healthy person to two existing cancer drugs can better control a type of blood cancer. The immune cells help fight cancer and infections. The two drugs work by killing cancer cells. These drugs have been used together to treat this type of blood cancer, showing improved response rates and survival compared to using one of the drugs alone.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service